The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Drug repositioning by integrating target information through a heterogeneous network model
Open accessAbstract
Motivation: The emergence of network medicine not only offers more opportunities for better and more complete understanding of the molecular complexities of diseases, but also serves as a promising tool for identifying new drug targets and establishing new relationships among diseases that enable drug repositioning. Computational approaches for drug repositioning by integrating information from multiple sources and multiple levels have the potential to provide great insights to the complex relationships among drugs, targets, disease genes and diseases at a system level. Results: In this article, we have proposed a computational framework based on a heterogeneous network model and applied the approach on drug repositioning by using existing omics data about diseases, drugs and drug targets. The novelty of the framework lies in the fact that the strength between a disease–drug pair is calculated through an iterative algorithm on the heterogeneous graph that also incorporates drug-target information. Comprehensive experimental results show that the proposed approach significantly outperforms several recent approaches. Case studies further illustrate its practical usefulness . Availability and implementation: http://cbc.case.edu Contact: jingli@cwru.edu Supplementary information: Supplementary data are available at Bioinformatics online.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of common molecular subsequences
Smith, T. F., & Waterman, M. S. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90087-5 · Cited by 9,940
Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders
Hamosh, A. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki033 · Cited by 3,420
Goh, K.-I., Cusick, M. E., Valle, D., Childs, B., Vidal, M., & Barabási, A.-L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701361104 · Cited by 3,242
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1126 · Cited by 1,831
Yıldırım, M. A., Goh, K.-I., Cusick, M. E., Barabási, A.-L., & Vidal, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1338 · Cited by 1,708
Predicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
Drug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248
Prediction of drug–target interaction networks from the integration of chemical and genomic spaces
Yamanishi, Y., Araki, M., Gutteridge, A., Honda, W., & Kanehisa, M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn162 · Cited by 1,147
PREDICT: a method for inferring novel drug indications with application to personalized medicine
Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 881
Associating Genes and Protein Complexes with Disease via Network Propagation
Vanunu, O., Magger, O., Ruppin, E., Shlomi, T., & Sharan, R. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000641 · Cited by 872
Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
Cheng, F., Liu, C., Jiang, J., Lu, W., Li, W., Liu, G., Zhou, W., Huang, J., & Tang, Y. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002503 · Cited by 818
Sirota, M., Dudley, J. T., Kim, J., Chiang, A. P., Morgan, A. A., Sweet-Cordero, A., Sage, J., & Butte, A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001318 · Cited by 799
Altshuler, D., Daly, M., & Kruglyak, L. (2000) · Nature Genetics · doi:10.1038/79839 · Cited by 762
A text-mining analysis of the human phenome
van Driel, M. A., Bruggeman, J., Vriend, G., Brunner, H. G., & Leunissen, J. A. M. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201585 · Cited by 664
Supervised prediction of drug–target interactions using bipartite local models
Bleakley, K., & Yamanishi, Y. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp433 · Cited by 628
Ardizzoni, A., Boni, L., Tiseo, M., Fossella, F. V., Schiller, J. H., Paesmans, M., Radosavljevic, D., Paccagnella, A., Zatloukal, P., Mazzanti, P., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk196 · Cited by 612
Steinbeck, C., Hoppe, C., Kuhn, S., Floris, M., Guha, R., & Willighagen, E. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777585274 · Cited by 462
Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses
Chiang, A. P., & Butte, A. J. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.103 · Cited by 268
Systematic Drug Repositioning Based on Clinical Side-Effects
Yang, L., & Agarwal, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028025 · Cited by 266
Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach
Emig, D., Ivliev, A., Pustovalova, O., Lancashire, L., Bureeva, S., Nikolsky, Y., & Bessarabova, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060618 · Cited by 241
Combining Drug and Gene Similarity Measures for Drug-Target Elucidation
Perlman, L., Gottlieb, A., Atias, N., Ruppin, E., & Sharan, R. (2011) · Journal of Computational Biology · doi:10.1089/cmb.2010.0213 · Cited by 218
Li, J., Zhu, X., & Chen, J. Y. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000450 · Cited by 185
Self-citationAssessing Drug Target Association Using Semantic Linked Data
Chen, B., Ding, Y., & Wild, D. J. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002574 · Cited by 166
Exploring the human diseasome: the human disease network
Goh, K.-I., & Choi, I. (2012) · Briefings in Functional Genomics · doi:10.1093/bfgp/els032 · Cited by 162
DRUG TARGET PREDICTIONS BASED ON HETEROGENEOUS GRAPH INFERENCE
Wang, W., Yang, S., & Li, J. (2012) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814447973_0006 · Cited by 141
Self-citationClozapine versus placebo in Huntington's disease: a double blind randomised comparative study
van Vugt, J. P. P., Siesling, S., Vergeer, M., van der Velde, E. A., & Roos, R. A. C. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.1.35 · Cited by 115
Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases
Dziadziuszko, R., Ardizzoni, A., Postmus, P. E., Smit, E. F., Price, A., Debruyne, C., LeGrand, C. C., & Giaccone, G. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00234-x · Cited by 108
Uncover disease genes by maximizing information flow in the phenome–interactome network
Chen, Y., Jiang, T., & Jiang, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr213 · Cited by 97
Pathway-based drug repositioning using causal inference
Li, J., & Lu, Z. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-s16-s3 · Cited by 96
Self-citationOlanzapine in Huntington's disease
Paleacu, D., Anca, M., & Giladi, N. (2002) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2002.01197.x · Cited by 89
Quetiapine in the Treatment of Behavioral Disturbances in Patients With Huntington’s Disease
Alpay, M., & Koroshetz, W. J. (2005) · Psychosomatics · doi:10.1176/appi.psy.47.1.70 · Cited by 78
Risperidone and the Treatment of Psychiatric, Motor, and Cognitive Symptoms in Huntington's Disease
Duff, K., Beglinger, L. J., O'Rourke, M. E., Nopoulos, P., Paulson, H. L., & Paulsen, J. S. (2008) · Annals of Clinical Psychiatry · doi:10.1080/10401230701844802 · Cited by 77
In Silico Gene Prioritization by Integrating Multiple Data Sources
Chen, Y., Wang, W., Zhou, Y., Shields, R., Chanda, S. K., Elston, R. C., & Li, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021137 · Cited by 67
Self-citation
Cited by
On the Opportunities and Risks of Foundation Models
Bommasani, R., Hudson, D. A., Adeli, E., Altman, R., Arora, S., von Arx, S., Bernstein, M. S., Bohg, J., Bosselut, A., Brunskill, E., et al. (2021) · arXiv · doi:10.48550/arxiv.2108.07258 · Cited by 2,676
Self-citationLuo, Y., Zhao, X., Zhou, J., Yang, J., Zhang, Y., Kuang, W., Peng, J., Chen, L., & Zeng, J. (2017) · Nature Communications · doi:10.1038/s41467-017-00680-8 · Cited by 916
Machine Learning in Drug Discovery: A Review
Dara, S., Dhamercherla, S., Jadav, S. S., Babu, C. M., & Ahsan, M. J. (2022) · Artificial Intelligence Review · doi:10.1007/s10462-021-10058-4 · Cited by 792
Zitnik, M., Nguyen, F., Wang, B., Leskovec, J., Goldenberg, A., & Hoffman, M. M. (2019) · Information Fusion · doi:10.1016/j.inffus.2018.09.012 · Cited by 675
Luo, T.-T., Lu, Y., Yan, S.-K., Xiao, X., Rong, X.-L., & Guo, J. (2020) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-019-3064-0 · Cited by 638
Metadata
- Authors
- Wang, W., Yang, S., Zhang, X., & Li, J.
- Venue
- Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-06-27
- Volume
- 30
- Issue
- 20
- Pages
- 2923-2930
- ISSN
- 1367-4803 (ISSN-L)
- 1367-4811
- OpenAlex
- W1998898494
- Cited by
- 335
- References
- 39
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.